Twin Euro Tablet 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Medix Pharmaceuticals Co., Ltd.
MFDS item code 201901407 · Approved 2019.03.08
This product's status changed to Expired on 2024.03.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled by monotherapy
This medication is effective for patients with essential hypertension whose blood pressure is difficult to control with monotherapy using amlodipine or telmisartan. It helps to lower blood pressure and reduce the risk of cardiovascular complications. Therefore, it is used in the treatment of essential hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with the individual components as described below, switching directly to this medication may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medication 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section “3. Patients requiring caution in administration.”) In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually.
○ Children: Use of this medication is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.
This medication can pose serious risks to the fetus, particularly in the second and third trimesters, and should not be taken by women who are pregnant or may become pregnant. Additionally, patients allergic to any component of this medication or those with severe liver impairment, severe hypotension, or certain specific heart conditions should not take it. Patients with impaired liver function or gastrointestinal diseases should use this medication with caution, and those with kidney issues or elderly patients should use it carefully. During use, side effects such as dizziness, edema, and blood pressure drops may occur, and any abnormal symptoms should be reported to a doctor immediately. Particularly when taken with other antihypertensives, specific diuretics, or potassium supplements, potassium levels in the blood may dangerously increase, thus it is essential to consult with healthcare professionals when taking in combination. If pregnant, this medication should be discontinued quickly, and it is also advisable for breastfeeding women to avoid taking this medication. Safety and efficacy in children and adolescents under 18 years old have not been sufficiently established, hence it is not recommended for them. In overdose situations, symptoms such as low blood pressure, dizziness, and heart rhythm abnormalities may occur, hence immediate emergency care is needed. This medication is not removed by dialysis, so caution is required. Store this medicine out of reach of children and do not transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light in. Additionally, it is recommended to store the medication at room temperature, ideally between 1 to 30 degrees Celsius.
Biconvex oval double-layer tablet in white and light gray.
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Medix Pharmaceuticals Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.